X

Vous n'êtes pas connecté

Maroc Maroc - THESTAR.COM.MY - Business - 28/Aug 03:22

Kenanga maintains 'outperform' on Karex after FDA approval

KUALA LUMPUR: Kenanga Investment Bank Bhd maintained its "outperform" rating on Karex Bhd, setting a share target price of RM1.12 after the United States Food and Drug Administration (FDA) approved its new synthetic condoms. Read full story

Articles similaires

Kenanga expects ringgit to trade closer to 4.40 level by year-end

thestar.com.my - 09/Sep 10:01

KUALA LUMPUR: Kenanga Investment Bank Bhd (Kenanga IB) expects the ringgit to trade closer to 4.40 by year-end, based on emerging signs which...

Sorry! Image not available at this time

Indies Pharma looking to double sales after securing FDA drug approval

jamaica-gleaner.com - 11/Sep 05:05

Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...

Sorry! Image not available at this time

Poh Huat's share price nears 52-week low after dismal Q3 results

nst.com.my - 13/Sep 10:42

KUALA LUMPUR: Shares of Poh Huat Resources Holdings Bhd slumped near its 52-week low today following dissappointing third quarter of financial year...

Sorry! Image not available at this time

KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

drugs.com - 03/Sep 20:09

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....

Sorry! Image not available at this time

Malaysia Airlines offers 30pct discount at Matta Fair

nst.com.my - 04/Sep 20:36

KUALA LUMPUR: Malaysia Airlines Bhd is offering up to 30 per cent discount on airfares for its economy and business class seats on all of its flights...

Hibiscus Petroleum declares 1.0 Sen final dividend for FY24; sets FY25 dividend targets

thestar.com.my - 12/Sep 09:58

KUALA LUMPUR: Hibiscus Petroleum Bhd has declared a final dividend of 1.0 sen per ordinary share for the financial year ended June 30, 2024 (FY24),...

Trading ideas: Yinson, CIMB, MAHB, MRCB, Mah Sing, Tan Chong, Pansar, Pharmaniaga

thestar.com.my - 02/Sep 00:45

KUALA LUMPUR: Stocks to watch on Monday include Yinson Holdings Bhd, CIMB Group Holdings Bhd, Malaysia Airports Holdings Bhd (MAHB), Malaysian...

Trading ideas: Yinson, CIMB, MAHB, MRCB, Mah Sing, Tan Chong, Pansar, Pharmaniaga

thestar.com.my - 02/Sep 00:45

KUALA LUMPUR: Stocks to watch on Monday include Yinson Holdings Bhd, CIMB Group Holdings Bhd, Malaysia Airports Holdings Bhd (MAHB), Malaysian...

Sorry! Image not available at this time

Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis

drugs.com - 13/Sep 07:09

HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Sorry! Image not available at this time

Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis

drugs.com - 13/Sep 07:09

HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Les derniers communiqués

  • Aucun élément